{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:38:37Z","timestamp":1781606317747,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014228","name":"Duke Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.amjsurg.2026.116874","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:00:37Z","timestamp":1771488037000},"page":"116874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Data-driven thresholds for tumor size and nodal involvement in oncocytic thyroid carcinoma: A population-based analysis"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7565-6205","authenticated-orcid":false,"given":"Milanie","family":"Milan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-0996","authenticated-orcid":false,"given":"Christina V.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3392-6217","authenticated-orcid":false,"given":"Todd W.","family":"Frieze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Scheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-3019","authenticated-orcid":false,"given":"Hadiza S.","family":"Kazaure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2026.116874_bib1","series-title":"StatPearls","article-title":"Oncocytic (H\u00fcrthle Cell) Thyroid Carcinoma","author":"Sherman","year":"2025"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116874_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cncy.22375","article-title":"H\u00fcrthle cell lesions of the thyroid: progress made and challenges remaining","volume":"129","author":"Wong","year":"2021","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/cancers13010026","article-title":"Thyroid H\u00fcrthle cell Carcinoma: clinical, pathological, and molecular features","volume":"13","author":"Kure","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116874_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/thy.2021.0424","article-title":"Follicular and Hurthle Cell Carcinoma: comparison of clinicopathological features and clinical outcomes","volume":"32","author":"Matsuura","year":"2022","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"S2","key":"10.1016\/j.amjsurg.2026.116874_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12918-019-0693-z","article-title":"Identification of H\u00fcrthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms","volume":"13","author":"Hao","year":"2019","journal-title":"BMC Syst Biol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/jcrt.jcrt_1797_22","article-title":"A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications","volume":"20","author":"Patel","year":"2024","journal-title":"J Cancer Res Therapeut"},{"key":"10.1016\/j.amjsurg.2026.116874_bib7","series-title":"World Health Organization., International Agency for Research on Cancer. WHO Classification of Tumours of Endocrine Organs","year":"1940"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib8","first-page":"59","article-title":"Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms","volume":"60","author":"J","year":"2024","journal-title":"Cesk Patol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116874_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/biomedicines12040712","article-title":"Molecular pathology of thyroid tumors: essential points to comprehend regarding the latest WHO classification","volume":"12","author":"Chiba","year":"2024","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116874_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3803\/EnM.2022.1553","article-title":"Update from the 2022 World health organization classification of thyroid tumors: a standardized diagnostic approach","volume":"37","author":"Jung","year":"2022","journal-title":"Endocrinol Metab Seoul Korea"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116874_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.semdp.2020.03.004","article-title":"H\u00fcrthle-cell neoplasms of the thyroid: an algorithmic approach to pathologic diagnosis in light of molecular advances","volume":"37","author":"Jalaly","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.amjsurg.2026.116874_bib13","article-title":"Clinical course and features of thyroid oncocytic (Hurthle cell) cancer: Comparison with thyroid follicular cancer","author":"Kursat","year":"2025","journal-title":"Rev Espa\u00f1ola Med Nucl Imagen Mol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12672-023-00839-4","article-title":"Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid","volume":"14","author":"Shi","year":"2023","journal-title":"Discov Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116874_bib15","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/clinem\/dgac448","article-title":"Radioactive iodine therapy does not improve cancer-specific survival in H\u00fcrthle Cell Carcinoma of the thyroid","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.amjsurg.2026.116874_bib16","article-title":"Oncocytic cell carcinoma of the thyroid: a case report and an overview of the diagnosis, treatment modalities, and prognosis","volume":"14","author":"Syed","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116874_bib17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/hed.27700","article-title":"Oncocytic carcinoma of the thyroid: conclusions from a 20-year patient cohort","volume":"46","author":"Gruszczynski","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.amjsurg.2026.116874_bib18","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.2147\/OTT.S119980","article-title":"H\u00fcrthle cell carcinoma: current perspectives","volume":"9","author":"Ahmadi","year":"2016","journal-title":"OncoTargets Ther"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116874_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archotol.129.2.207","article-title":"Survival and prognosis in H\u00fcrthle cell carcinoma of the thyroid gland","volume":"129","author":"Bhattacharyya","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjsurg.2026.116874_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7150\/jca.1.23","article-title":"Age and tumor size predicts lymph node involvement in H\u00fcrthle Cell Carcinoma","volume":"1","author":"Guerrero","year":"2010","journal-title":"J Cancer"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116874_bib21","doi-asserted-by":"crossref","first-page":"e2334","DOI":"10.1210\/clinem\/dgae084","article-title":"Clinical and histopathological risk factors for radioactive iodine\u2013refractory follicular and oncocytic thyroid carcinoma","volume":"109","author":"Stegenga","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116874_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.16956\/jes.2024.24.3.49","article-title":"Clinical considerations of oncocytic thyroid cancer: a review","volume":"24","author":"Kim","year":"2024","journal-title":"J Endocr Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116874_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/cncr.27770","article-title":"Hurthle cell carcinoma: a population-level analysis of 3311 patients","volume":"119","author":"Goffredo","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116874_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.surg.2022.07.007","article-title":"Prognostic factors and survival analysis of Hurthle cell carcinoma: a population-based study","volume":"172","author":"Humphreys","year":"2022","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.amjsurg.2026.116874_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116874_bib26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s11605-018-3717-x","article-title":"What is the minimum number of examined lymph nodes after neoadjuvant therapy in rectal cancer?","volume":"22","author":"Gao","year":"2018","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"issue":"5","key":"10.1016\/j.amjsurg.2026.116874_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/jamaoncol.2016.5829","article-title":"Association of delayed adjuvant chemotherapy with survival after lung cancer surgery","volume":"3","author":"Salazar","year":"2017","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116874_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.4298","article-title":"Development and validation of a modified pathologic nodal classification system for cutaneous melanoma","volume":"156","author":"Nguyen","year":"2021","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116874_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SLA.0000000000002095","article-title":"The effect of hospital volume on breast cancer mortality","volume":"267","author":"Greenup","year":"2018","journal-title":"Ann Surg"},{"issue":"36","key":"10.1016\/j.amjsurg.2026.116874_bib30","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1200\/JCO.2016.68.9372","article-title":"Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems","volume":"34","author":"Adam","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116874_bib31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/cen.14657","article-title":"Optimal cutoff values of primary tumour size to better predict long-term outcomes in patients with papillary thyroid carcinoma undergoing total thyroidectomy: a preliminary study using restricted cubic spline analysis","volume":"96","author":"Jang","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116874_bib32","first-page":"878","article-title":"Molecular basis of hurthle cell Papillary thyroid Carcinoma1","volume":"85","author":"Cheung","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116874_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00129039-200412000-00007","article-title":"Pathologic Study and clinical significance of H\u00fcrthle cell Papillary thyroid carcinoma","volume":"12","author":"Mai","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116874_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archotol.132.1.54","article-title":"H\u00fcrthle cell tumors: applying molecular markers to define a new management algorithm","volume":"132","author":"Maxwell","year":"2006","journal-title":"Arch Otolaryngol Neck Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116874_bib35","first-page":"93","article-title":"The Eighth Edition AJCC cancer Staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116874_bib36","article-title":"Thyroid cancer staging: historical evolution and analysis from macrocarcinoma to Microcarcinoma","volume":"17","author":"Duque","year":"2025","journal-title":"Cureus"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:52:58Z","timestamp":1777449178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961026000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S0002961026000577"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116874","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data-driven thresholds for tumor size and nodal involvement in oncocytic thyroid carcinoma: A population-based analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116874"}}